Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.16 - $0.3 $45 - $85
-284 Reduced 73.58%
102 $0
Q4 2023

Feb 13, 2024

SELL
$0.23 - $0.4 $33 - $57
-144 Reduced 27.17%
386 $0
Q3 2023

Nov 14, 2023

SELL
$0.28 - $1.04 $6 - $24
-24 Reduced 4.33%
530 $0
Q2 2023

Aug 14, 2023

SELL
$0.78 - $1.0 $16 - $21
-21 Reduced 3.65%
554 $0
Q1 2023

May 09, 2023

BUY
$0.8 - $1.33 $460 - $764
575 New
575 $0
Q2 2022

Aug 15, 2022

BUY
$3.88 - $7.41 $2,525 - $4,823
651 Added 161.54%
1,054 $5,000
Q1 2022

May 12, 2022

SELL
$6.31 - $10.09 $2,214 - $3,541
-351 Reduced 46.55%
403 $3,000
Q4 2021

Feb 14, 2022

SELL
$8.38 - $13.72 $2,849 - $4,664
-340 Reduced 31.08%
754 $6,000
Q3 2021

Nov 15, 2021

BUY
$6.65 - $12.1 $7,275 - $13,237
1,094 New
1,094 $11,000

Others Institutions Holding SNPX

# of Institutions
1
Shares Held
30K
Call Options Held
0
Put Options Held
0

About Synaptogenix, Inc.


  • Ticker SNPX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 6,840,630
  • Market Cap $20.2M
  • Description
  • Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodeg...
More about SNPX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.